[go: up one dir, main page]

WO2008056139A3 - Transdermal therapy - Google Patents

Transdermal therapy Download PDF

Info

Publication number
WO2008056139A3
WO2008056139A3 PCT/GB2007/004245 GB2007004245W WO2008056139A3 WO 2008056139 A3 WO2008056139 A3 WO 2008056139A3 GB 2007004245 W GB2007004245 W GB 2007004245W WO 2008056139 A3 WO2008056139 A3 WO 2008056139A3
Authority
WO
WIPO (PCT)
Prior art keywords
transdermal therapy
zolpidem
transdermal
therapy
caffeine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/004245
Other languages
French (fr)
Other versions
WO2008056139A2 (en
Inventor
Ralf P Clauss
Timothy Simon Shilton
Andrew Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiziana Life Sciences Ltd
Original Assignee
Regen Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0622285A external-priority patent/GB0622285D0/en
Priority claimed from GB0705689A external-priority patent/GB0705689D0/en
Application filed by Regen Therapeutics PLC filed Critical Regen Therapeutics PLC
Publication of WO2008056139A2 publication Critical patent/WO2008056139A2/en
Publication of WO2008056139A3 publication Critical patent/WO2008056139A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to transdermal pharmaceutical compositions containing zolpidem an also to compositions comprising zolpidem in combination with caffeine.
PCT/GB2007/004245 2006-11-08 2007-11-08 Transdermal therapy Ceased WO2008056139A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0622285A GB0622285D0 (en) 2006-11-08 2006-11-08 Transdermal therapy
GB0622285.5 2006-11-08
GB0705689.8 2007-03-21
GB0705689A GB0705689D0 (en) 2007-03-21 2007-03-21 Therapeutic applications of Zolpidem

Publications (2)

Publication Number Publication Date
WO2008056139A2 WO2008056139A2 (en) 2008-05-15
WO2008056139A3 true WO2008056139A3 (en) 2008-10-02

Family

ID=38858432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/004245 Ceased WO2008056139A2 (en) 2006-11-08 2007-11-08 Transdermal therapy

Country Status (2)

Country Link
GB (1) GB2443928A (en)
WO (1) WO2008056139A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033835A1 (en) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Controlled-release dosage forms comprising zolpidem or a salt thereof
EP1201230A2 (en) * 2000-10-27 2002-05-02 BioChemics, Inc. Solution-based transdermal drug delivery system comprising a vasodilator
US6638528B1 (en) * 2000-01-20 2003-10-28 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
US20040220262A1 (en) * 1999-12-16 2004-11-04 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US20040265239A1 (en) * 1997-10-01 2004-12-30 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
WO2005060945A2 (en) * 2003-12-24 2005-07-07 Archimedes Development Limited Intranasal compositions comprising zolpidem
US20050150190A1 (en) * 2000-03-14 2005-07-14 Noven Pharmaceuticals, Inc. Packaging meterials for transdermal drug delivery systems
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
US20060078603A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065403C (en) * 1989-09-14 1996-06-18 Gary W. Cleary Transdermal delivery device having delayed onset
IT1276522B1 (en) * 1995-04-07 1997-10-31 Elena Benincasa USE OF ZOLPIDEM FOR THE THERAPEUDIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DYSFUNSION AND NEURAL CIRCUITS OF
US20040204443A1 (en) * 2003-01-27 2004-10-14 Arthur Zaks Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives
AU2004237943A1 (en) * 2003-05-19 2004-11-25 Sciencom Ltd Further therapeutic use of zolpidem

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265239A1 (en) * 1997-10-01 2004-12-30 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
WO2000033835A1 (en) * 1998-12-04 2000-06-15 Sanofi-Synthelabo Controlled-release dosage forms comprising zolpidem or a salt thereof
US20040220262A1 (en) * 1999-12-16 2004-11-04 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6638528B1 (en) * 2000-01-20 2003-10-28 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
US20050150190A1 (en) * 2000-03-14 2005-07-14 Noven Pharmaceuticals, Inc. Packaging meterials for transdermal drug delivery systems
EP1201230A2 (en) * 2000-10-27 2002-05-02 BioChemics, Inc. Solution-based transdermal drug delivery system comprising a vasodilator
WO2005060945A2 (en) * 2003-12-24 2005-07-07 Archimedes Development Limited Intranasal compositions comprising zolpidem
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
US20060078603A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size

Also Published As

Publication number Publication date
WO2008056139A2 (en) 2008-05-15
GB0722015D0 (en) 2007-12-19
GB2443928A (en) 2008-05-21

Similar Documents

Publication Publication Date Title
IL283205A (en) Cell binding agent drug conjugates, compositions comprising the same and uses thereof
IL206395A (en) N-heterocyclyl-7-oxo-6-sulfooxy-1,6-diazabicyclo[3.2.1]octane-2-carboxamides and pharmaceutical compositions comprising them
WO2007109812A3 (en) Immunopotentiating compounds
IL193240A0 (en) Dihydrodiazepine derivatives and pharmaceutical compositions containing the same
IL191902A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
EP2143713A4 (en) Novel pyrrolinone derivative and medicinal composition containing the same
IL198509A0 (en) Azaindole derivatives, compositions containing the same and uses thereof
IL221952A (en) 2,3-dihydro-1h-inden-1-yl-2,7- diazaspiro[3.5] nonane derivatives and pharmaceutical compositions comprising the same
IL186458A0 (en) Skin enrichment using coq10 as the delivery system
TWI350756B (en) 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
IL196033A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
ZA200902084B (en) Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
IL213365A (en) Imidazopyrazine and pharmaceutical compositions comprising the same
IL204844A (en) Quinolone analogs, pharmaceutical compositions comprising the same and uses thereof
IL206808A (en) Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof
IL196601A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
IL195488A (en) Compounds, pharmaceutical compositions comprising the same and uses thereof
IL211892A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL211890A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL211889A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
PL2083809T3 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes for the treatment of depression.
WO2007084857A3 (en) Methods and compositions for treating cell proliferative disorders
IL211891A0 (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof
WO2010021607A3 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07824478

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009535794

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 07824478

Country of ref document: EP

Kind code of ref document: A2